Aclarion, Inc.
Aclarion, Inc. (ACON) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
acon · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Aclarion, Inc. (ACON) measures how much investors pay for each dollar of the company's trailing earnings. ACON's current PE ratio of N/A is calculated by dividing its stock price of $3.36 by its TTM earnings per share of -$3.78.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2019 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Medical - Healthcare Information Services · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Aclarion, Inc.You ACON | $2M | N/A | — | -$3.78 |
 Bullfrog AI Holdings, Inc. Common Stock BFRG | $7M | N/A | — | -$0.63 |
 BNB Plus Corp. BNBX | $1M | N/A | — | -$29.29 |
 Can-Fite BioPharma Ltd. CANF | $2M | N/A | — | -$12.02 |
 Clearmind Medicine Inc. CMND | $4M | N/A | — | -$3.03 |
 Ensysce Biosciences, Inc. ENSC | $2M | N/A | — | -$3.98 |
 Kazia Therapeutics Limited KZIA | $18M | N/A | — | -$18.90 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-13.60 | — | |
2024-12-31 FY2024 | — | $-7416.89 | — | |
2023-12-31 FY2023 | — | $-79782.22 | — | |
2022-12-31 FY2022 | — | $-167546.51 | — | |
2021-12-31 FY2021 | — | $-99768.11 | — | |
2020-12-31 FY2020 | — | $-93418.70 | — | |
2019-12-31 FY2019 | — | $-81004.10 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Aclarion, Inc. (ACON) measures how much investors pay for each dollar of the company's trailing earnings. ACON's current PE ratio of N/A is calculated by dividing its stock price of $3.36 by its TTM earnings per share of -$3.78.
Frequently asked questions
ACON pe ratio · 6 questionsACON's current PE ratio is N/A as of 2026-06-08, based on a stock price of $3.36 and TTM EPS of -$3.78. Data sourced from Financial Modeling Prep via ACON's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Aclarion, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08